Silver Spring, MDOn December 18, 2024, the FDA issued a warning about the dangers of unapproved GLP-1 drugs which are often marketed as better/cheaper/stronger alternatives to Ozempic. Even branded Ozempic has been... Read more »
Washington, DC In a surprise move, the Food and Drug Administration has authorized the Multidisciplinary Association for Psychedelic Studies (MAPS) to conduct clinical trials to study the effectiveness of smoking cannabis to treat... Read more »
Santa Clara, CATwo lawmakers in March 2023 wrote a letter to the FDA, urging it to ban harmful chemicals in hair relaxers. Last month, those lawmakers sent another letter to the agency... Read more »
Marissa Zupancic is JURIST’s Washington DC Correspondent, a JURIST Senior Editor and a 3L at the University of Pittsburgh School of Law. She’s stationed in Washington during her Semester in DC. Today I... Read more »
In one of the last guidances released in 2023, the Federal Food and Drug Administration (FDA) finalized guidance for direct-to-consumer (DTC) prescription drug advertisements, specifically advertisements in television and radio format (CCN Final... Read more »
Key Takeaways What Happened: The Food and Drug Administration (FDA) released four updates regarding MoCRA in December. Who’s Impacted: Cosmetic product manufacturers. What Should You Do: Companies should stay up to date... Read more »
AbbVie, AstraZeneca, and GSK are among the 10 companies now under scrutiny by the Federal Trade Commission, which is cracking down on businesses it says improperly or inaccurately placed items on a... Read more »
In response to a spike in addiction to cocaine, meth or prescription stimulants, often in combination with opioids, the Food and Drug Administration is calling on drugmakers to develop treatments for stimulant... Read more »
FDA Issues Warning Letters to Three Infant Formula Manufacturers Source link Reach Out Don’t hesitate to reach out to us to discuss your specific needs. Our team is ready and eager to... Read more »
